Evaluation of Group Lifestyle Balance Maintenance Strategies
1 other identifier
interventional
60
1 country
1
Brief Summary
Heart disease is a leading cause of death in people in the United States. It is a major problem for those with diabetes. Conditions called the metabolic syndrome and pre-diabetes increase risk for diabetes and heart disease. The metabolic syndrome is a group of disorders that occur at the same time. Overall, one in four American adults has the metabolic syndrome. It is more common in people over the age of 40. The metabolic syndrome includes: 1) large waist size, 2) high triglycerides, 3) low HDL cholesterol, 4) high blood pressure and 5) high fasting blood sugar. People with the metabolic syndrome have at least three of these five risk factors. Pre-diabetes is considered to be present in those with high fasting blood sugar levels below the diabetes range. Research has shown that type 2 diabetes and the metabolic syndrome may be prevented or delayed by making lifestyle changes. It is not known what will most help people continue these healthy changes over time. The purpose of this study is to look at ways to help people continue the healthy lifestyle changes they have made while taking part in a diabetes prevention program called Group Lifestyle Balance (GLB).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes
Started Mar 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 24, 2009
CompletedFirst Posted
Study publicly available on registry
March 26, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedResults Posted
Study results publicly available
February 9, 2016
CompletedJune 24, 2016
May 1, 2016
1.4 years
March 24, 2009
January 11, 2016
May 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Weight
Weight was measured twice without shoes with the average computed; participants were asked to remove their shoes at each measure.
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Secondary Outcomes (9)
Change in Total Cholesterol
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Change in HDL Cholesterol
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Change in LDL Cholesterol
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Change in Triglycerides
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Change in Fasting Glucose
Measured at 8 months post intervention and 4 months post-randomization to maintenance group
- +4 more secondary outcomes
Study Arms (2)
GLB Traditional Maintenance (TM)
ACTIVE COMPARATORGroup Lifestyle Balance (GLB) program Traditional Maintenance: After completion of the GLB 12 core sessions, participants who are randomly assigned to GLB program Traditional Maintenance (TM) will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions.
GLB-Carb-focused Maintenance (CF)
ACTIVE COMPARATORGroup Lifestyle Balance (GLB) program Carb-focused Maintenance: After completion of the GLB 12 core sessions, participants randomly assigned to GLB Carb-focused Maintenance (CF) will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information regarding healthy carbohydrate intake and hunger management.
Interventions
After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. Participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management.
After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. GLB-CF participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management.
Eligibility Criteria
You may qualify if:
- Non-diabetic patients with metabolic syndrome AND/OR pre-diabetes are eligible for this project based on the following criteria:
- Metabolic Syndrome:
- Patients with BMI ≥ 25 kg/m2, with at least 3 of the following risk factors for metabolic syndrome:
- Waist circumference (\>40 inches men, \>35 inches women)
- Blood pressure ≥130 mmHg (systolic) or ≥85 mmHg (diastolic) OR history of diagnosed hypertension
- Low HDL level (\<40mg/dL men, \<50 mg/dL women)
- Elevated triglyceride level ≥150 mg/dL
- Fasting glucose ≥100mg/dL and \<126mg/dL
- Pre-diabetes:
- Patients with a BMI ≥25 kg/m2 and pre-diabetes (fasting glucose ≥100 mg/dL and \<126mg/dL)
- All measures should have been taken within one year of enrollment into the study. A permission for physical activity form must be signed by the participant's physician in order to take part in the study.
You may not qualify if:
- Previous diabetes or diabetes diagnosed as a result of the screening
- Age \<18 years old
- Women who are currently (or within past 6-weeks) pregnant or lactating
- Any patient deemed by their physician not to be a candidate
- Any patient planning to leave the area before the end of the GILS
- Any patient who is unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- Robert C. Atkins Foundationcollaborator
Study Sites (1)
Diabetes Prevention Support Center
Pittsburgh, Pennsylvania, 15213, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
The sample size was small and included primarily white individuals, so these results may not be generalizable to other groups. The CPC was not carbohydrate restricted and may not be directly comparable to studies that focus on carbohydrate reduction.
Results Point of Contact
- Title
- Trevor J Orchard
- Organization
- University of Pittsburgh
Study Officials
- PRINCIPAL INVESTIGATOR
Trevor J Orchard, MD
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 24, 2009
First Posted
March 26, 2009
Study Start
March 1, 2009
Primary Completion
August 1, 2010
Study Completion
August 1, 2010
Last Updated
June 24, 2016
Results First Posted
February 9, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share